Khasabova I A, Harding-Rose C, Simone D A, Seybold V S
Department of Neuroscience, University of Minnesota, Minneapolis, Minnesota 55455, USA.
J Neurosci. 2004 Feb 18;24(7):1744-53. doi: 10.1523/JNEUROSCI.4298-03.2004.
Inhibition of primary afferent neurons contributes to the antihyperalgesic effects of opioid and CB1 receptor agonists. Two bioassays were used to compare the effects of the CB1 receptor agonist CP 55,940 and morphine on dissociated adult rat DRG neurons. Both agonists inhibited the increase in free intracellular Ca2+ concentration evoked by depolarization; however, effects of CP 55,940 occurred primarily in large neurons (cell area, >800 microm2), whereas morphine inhibited the response in smaller neurons. Cotreatment with selective blockers of L-, N-, and P/Q-type voltage-dependent Ca2+ channels indicated that CB1 receptors on DRG neurons couple solely with N-type channels but opioid receptors couple with multiple subtypes. Experiments with selective agonists and antagonists of opioid receptors indicated that mu and delta, but not kappa, receptors contributed to the inhibitory effect of morphine on voltage-dependent Ca2+ influx. Because Ca2+ channels underlie release of transmitters from neurons, the effects of opioid agonists and CP 55,940 on depolarization-evoked release of calcitonin gene-related peptide (CGRP) were compared. Morphine inhibited release through delta receptors but CP 55,940 had no effect. Colocalization of CGRP with delta-opioid but not mu-opioid or CB1 receptor immunoreactivity in superficial laminae of the dorsal horn of the spinal cord was consistent with the data for agonist inhibition of peptide release. Therefore, CB1 and opioid agonists couple with different voltage-dependent Ca2+ channels in different populations of DRG neurons. Furthermore, differences occur in the distribution of receptors between the cell body and terminals of DRG neurons. The complementary action of CB1 and opioid receptor agonists on populations of DRG neurons provides a rationale for their combined use in modulation of somatosensory input to the spinal cord.
初级传入神经元的抑制作用有助于阿片类药物和CB1受体激动剂的抗痛觉过敏效应。采用两种生物测定法比较CB1受体激动剂CP 55,940和吗啡对成年大鼠离体背根神经节(DRG)神经元的作用。两种激动剂均抑制去极化引起的细胞内游离Ca2+浓度升高;然而,CP 55,940的作用主要发生在大神经元(细胞面积>800平方微米),而吗啡抑制较小神经元的反应。用L型、N型和P/Q型电压依赖性Ca2+通道的选择性阻滞剂联合处理表明,DRG神经元上的CB1受体仅与N型通道偶联,而阿片受体与多种亚型偶联。阿片受体选择性激动剂和拮抗剂的实验表明,μ和δ受体而非κ受体介导吗啡对电压依赖性Ca2+内流的抑制作用。由于Ca2+通道是神经元递质释放的基础,因此比较了阿片类激动剂和CP 55,940对去极化诱发的降钙素基因相关肽(CGRP)释放的影响。吗啡通过δ受体抑制释放,但CP 55,940无作用。脊髓背角浅层中CGRP与δ阿片受体而非μ阿片受体或CB1受体免疫反应性的共定位与激动剂抑制肽释放的数据一致。因此,CB1和阿片类激动剂在不同群体的DRG神经元中与不同的电压依赖性Ca2+通道偶联。此外,DRG神经元的细胞体和终末之间的受体分布存在差异。CB1和阿片受体激动剂对DRG神经元群体的互补作用为它们联合用于调节脊髓体感输入提供了理论依据。